A customer shops in a Kroger grocery store on July 15, 2022 in Houston, Texas. Brandon Bell | Getty Images Investors have cheered a new class of weight loss drugs for their ability to help people shed unwanted pounds, but the findings of a recent poll underscore the challenges patients face if they cease treatment. … Read more
Demand for the drugs is unlikely to slow down in 2024, especially as treatments gradually become more accessible. Much of Wall Street believes the weight loss drug market will only expand, with some analysts projecting that it will be worth $100 billion by the end of the decade. Goldman Sachs analysts expect 15 million U.S. adults … Read more
Scientists have begun investigating whether so-called miracle obesity drugs can be used to help treat conditions such as dementia and alcohol addiction. Recent trials have pointed to the drugs’ efficacy in curbing major cardiovascular events and reducing heart-failure related symptoms. The findings mark a milestone as pharmaceutical companies such as Novo Nordisk and Eli Lilly … Read more
Novo Nordisk’s obesity drug Wegovy slashed the risk of serious heart problems by 20% in a large clinical trial. That landmark finding could put more pressure on U.S. insurers to cover the blockbuster medication and similar weight loss treatments. But organizations representing insurers emphasized that the data is still preliminary, and concerns remain about the … Read more